NJ A5117 | 2016-2017 | Regular Session

Note: Carry Foward to future A2270

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on July 13 2017 - 25% progression, died in committee
Action: 2017-07-13 - Introduced, Referred to Assembly Health and Senior Services Committee
Pending: Assembly Health and Senior Services Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Prohibits substitution of prescribed epilepsy medication without notification and written consent of physician and patient; requires prescription to include notation of epilepsy diagnosis.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prohibits substitution of prescribed epilepsy medication without notification and written consent of physician and patient; requires prescription to include notation of epilepsy diagnosis.

Sponsors


History

DateChamberAction
2017-07-13AssemblyIntroduced, Referred to Assembly Health and Senior Services Committee

Same As/Similar To

A5117 (Carry Over) 2017-07-13 - Introduced, Referred to Assembly Health and Senior Services Committee

Subjects


New Jersey State Sources


Bill Comments

feedback